Literature DB >> 9787362

Preseptal and orbital cellulitis in childhood. A changing microbiologic spectrum.

S P Donahue1, G Schwartz.   

Abstract

OBJECTIVE: The authors sought to determine whether the microbiologic spectrum of preseptal and orbital cellulitis had changed over the past decade.
DESIGN: A retrospective chart review of all inpatient and outpatient children with an ICD-9 diagnosis of preseptal or orbital cellulitis seen at Vanderbilt University Medical Center since the introduction of the Haemophilus influenzae type-B (HiB) vaccine (1986-1996). MAIN OUTCOME MEASURES: Blood and abscess cultures from children with preseptal and orbital cellulitis were tabulated.
RESULTS: During this period, 70 cases of preseptal cellulitis were seen. Blood cultures were obtained in 59 cases; only 6 were positive. Five cultures grew Streptococcus species. The one positive H. influenzae culture occurred in 1987 in a child who did not receive the HiB vaccine. There have been no new patients with preseptal cellulitis and H. influenzae bacteremia at Vanderbilt for 10 years. There were ten cases of orbital cellulitis, of which blood or abscess or both were cultured in eight. Six cases had positive cultures. Four cultures grew Streptococcus species. The other two grew H. influenzae and mixed H. influenzae/gram-positive cocci.
CONCLUSION: The incidence of hemophilus-associated bacteremia in patients with preseptal cellulitis has decreased dramatically over the past 10 years. Streptococcus species now are the predominant cause. Orbital cellulitis due to H. influenzae may still occur, but it is much less likely. A more conservative approach to the diagnosis and management of preseptal and orbital cellulitis may be warranted.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9787362     DOI: 10.1016/S0161-6420(98)91038-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Should we vaccinate for glaucoma surgery?

Authors:  R R Seemongal-Dass; T E James
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  Dental infection presenting with ipsilateral parapharyngeal abscess and contralateral orbital cellulitis - a case report.

Authors:  Zunaina Embong; Shatriah Ismail; Asokumaran Thanaraj; Adil Hussein
Journal:  Malays J Med Sci       Date:  2007-07

3.  Biotypes and serotypes of Haemophilus influenzae ocular isolates.

Authors:  A M Alrawi; K C Chern; V Cevallos; T Lietman; J P Whitcher; T P Margolis; E T Cunningham
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

Review 4.  Epidemiology and Management of Orbital Cellulitis in Children.

Authors:  Brenda I Anosike; Veena Ganapathy; Mari M Nakamura
Journal:  J Pediatric Infect Dis Soc       Date:  2022-05-30       Impact factor: 5.235

5.  Understanding pediatric bacterial preseptal and orbital cellulitis.

Authors:  Mithra O Gonzalez; Vikram D Durairaj
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

6.  Management of preseptal and orbital cellulitis.

Authors:  Seongmu Lee; Michael T Yen
Journal:  Saudi J Ophthalmol       Date:  2010-12-10

7.  Corticosteroids for periorbital and orbital cellulitis.

Authors:  Emily Kornelsen; Sanjay Mahant; Patricia Parkin; Lily Yuxi Ren; Yohann A Reginald; Samir S Shah; Peter J Gill
Journal:  Cochrane Database Syst Rev       Date:  2021-04-28

8.  Bilateral cavernous sinus thrombosis complicating sinusitis.

Authors:  M Absoud; F Hikmet; P Dey; M Joffe; E Thambapillai
Journal:  J R Soc Med       Date:  2006-09       Impact factor: 18.000

9.  The hot orbit: orbital cellulitis.

Authors:  Imtiaz A Chaudhry; Waleed Al-Rashed; Yonca O Arat
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

10.  Nine years' review on preseptal and orbital cellulitis and emergence of community-acquired methicillin-resistant Staphylococus aureus in a tertiary hospital in India.

Authors:  Datta G Pandian; Ramesh K Babu; A Chaitra; A Anjali; Vasudev A Rao; Renuka Srinivasan
Journal:  Indian J Ophthalmol       Date:  2011 Nov-Dec       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.